Metraipolis › archive › dc_cd9b92571a67

Moving Mendelian Randomization From Traditional Risk Factors to Molecular Targets for Drug Development and Clinical Trials in Nephrology — Europe PMC PMID:41858318

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41858318
DOI: 10.1016/j.ekir.2026.106350
License (as archived): solo-consultazione
Archived: 2026-11-05T21:30:26.753Z
SHA-256 of the archived text: 9ec2d32f75f96f4f453deb182042cf7254f8ab6f809b58bd25153b4b0e90dab0
Stable URL of this page: https://metraipolis.com/documento/dc_cd9b92571a67

How to cite

Moving Mendelian Randomization From Traditional Risk Factors to Molecular Targets for Drug Development and Clinical Trials in Nephrology — Europe PMC PMID:41858318 — Europe PMC (en), https://europepmc.org/article/MED/41858318 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd9b92571a67 (Metraipolis archive dc_cd9b92571a67, sha256 9ec2d32f75f96f4f453deb182042cf7254f8ab6f809b58bd25153b4b0e90dab0)

BibTeX

@misc{dccd9b92571a67,
  title = {Moving Mendelian Randomization From Traditional Risk Factors to Molecular Targets for Drug Development and Clinical Trials in Nephrology — Europe PMC PMID:41858318},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41858318},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd9b92571a67; sha256 9ec2d32f75f96f4f453deb182042cf7254f8ab6f809b58bd25153b4b0e90dab0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41858318. Agents can read the archived copy with the MCP tool read_document.